no statement of use filed
on 30 Jul 2012
Last Applicant/ Owned by
601 Gateway Boulevard
South San Francisco
CA
940807031
Serial Number
85010595 filed on 09th Apr 2010
Registration Number
N/A
Correspondent Address
Julie L. Dalke
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
"BIOPHARMA"
"BIOPHARMA" pharmaceutical preparations for the treatment of Tangiers disease, nonalcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), cystic fibrosis, human immunodeficiency virus (HIV), diabetes, hyperlipidemia, cancer, atherosclerosis, hypertension, insulin resistance, dyslipidemia, and hepatic cholestasis; pharmaceutical preparations for the treatment of the metabolic Read More
pharmaceutical preparations for the treatment of Tangiers disease, nonalcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), cystic fibrosis, human immunodeficiency virus (HIV), diabetes, hyperlipidemia, cancer, atherosclerosis, hypertension, insulin resistance, dyslipidemia, and hepatic cholestasis; pharmaceutical preparations for the treatment of the metabolic system, the central nervous system, the peripheral nervous system, the liver, the immune system, the renal system, and the cardiovascular system; pharmaceutical preparations for the treatment of metabolic diseases and disorders, infectious diseases, autoimmune diseases and disorders, inflammatory disorders, and cardiovascular disease; pharmaceutical preparations for the treatment of renal diseases, disorders and dysfunction; pharmaceutical preparations for the prevention and treatment of organ rejection; pharmaceutical preparations for use in tissue and organ transplantation, for adjuvant use in tissue and organ transplantation, for use in oncology, and for use in chemotherapy; pharmaceutical preparations and substances for the treatment of viral related diseases and disorders, and immune system related diseases and disorders; pharmaceutical preparations and substances for the treatment of pain; pharmaceuticals, namely, anti-infectives, immunosuppressants, anti-inflamatories, and antivirals; analgesic pharmaceutical preparations; anti-diabetic pharmaceuticals; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals
No 85010595
No Service/Collective Mark
No 048690-7-US0
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
30th Jul 2012 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
30th Jul 2012 | ABANDONMENT - NO USE STATEMENT FILED |
19th Jan 2012 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
18th Jan 2012 | EXTENSION 2 GRANTED |
18th Jan 2012 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
15th Dec 2011 | TEAS EXTENSION RECEIVED |
15th Dec 2011 | EXTENSION 2 FILED |
14th Jun 2011 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
10th Jun 2011 | EXTENSION 1 GRANTED |
10th Jun 2011 | EXTENSION 1 FILED |